Immunogenicity 1807

summary
Sample ID
3978
Response
Negative
Tumor Type
Bile duct cancer
Gene Symbol
FBXW9
Transcript ID
ENST00000544494
HLA INFO
DQA*05:01 / DQB*04:02
TCR INFO

No TCR info found!

T cell Tumor cell { DQA*05:01 DQB*04:02
sequence
Full length protein sequence (196 aa)
MRASS
1
AVLCL
6
SYLPD
11
ILVTG
16
TYDKK
21
VTIYD
26
PRAGP
31
ALLKH
36
QQLHS
41
RPVLT
46
LLADD
51
RHIIS
56
GSEDH
61
TLVVV
66
DRRAN
71
SVLQR
76
LQLDS
81
YLLCM
86
SYQEP
91
QLWAG
96
DNQGL
101
LHVFA
106
NRNGC
111
FQLIR
116
SFDVG
121
HSFPI
126
TGIQY
131
SVGAL
136
YTTST
141
DKTIR
146
VHVPT
151
DPPRT
156
ICTRR
161
HDNGL
166
NRVCA
171
EGNLV
176
VAGSG
181
DLSLE
186
VWRLQ
191
A
196
Mutation Information
DNA mutation:
None
Peptide Range:
126 ~ 150
Mut AA position:
138 (13 in Wild Type peptide)
Alignment
Wild Type:
"HSFPITGIQYSVGALYTTSTDKTIR
||||||||||||.||||||||||||
Mutant:
HSFPITGIQYSVRALYTTSTDKTIR"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) FBXW9

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay